长春高新：控股子公司重组人生长激素注射液新适应症获得批准

array(1) { [475001]=> array(2) { [2]=> array(4) { [0]=> string(12) "并购重组" [1]=> string(12) "长春高新" [2]=> string(18) "核准资产重组" [3]=> string(21) "重组人生长激素" } [4]=> array(1) { [0]=> string(19) "同花顺7x24快讯" } } }